Cytarabine, also known as Ara-C, is a chemotherapy medication used primarily in the treatment of certain types of cancer. It is particularly effective against hematological malignancies, such as acute myeloid leukemia (AML) and non-Hodgkin lymphoma. Structurally, cytarabine is a nucleoside analog that interferes with DNA synthesis, which is crucial for cancer cell proliferation.
